Barcode

About:

Barcode designs a proprietary technology for use for personalized cancer drug screening.

Website: https://www.barcode-diagnostics.com/

Top Investors: OurCrowd

Description:

Barcode designs a proprietary technology designed for use for personalized cancer drug screening. Its proprietary technology quickly and reliably assesses the efficacy of different cancer drugs directly on the tumor within the patient's own body, enabling physicians to access a new tool that matches each patient with the optimally potent medicine, during the different stages of the disease to improve cancer care.

Total Funding Amount:

$4M

Headquarters Location:

Nazareth, HaZafon, Israel

Founded Date:

2017-07-01

Contact Email:

office(AT)barcode-diagnosis.com

Founders:

Annie Sabbah, Ronen Eavri

Number of Employees:

1-10

Last Funding Date:

2019-03-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai